Published in J Virol on August 01, 2004
IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog (2008) 4.70
Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog (2008) 2.38
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A (2006) 2.02
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol (2007) 1.90
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86
Protective role of beta interferon in host defense against influenza A virus. J Virol (2006) 1.80
Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proc Natl Acad Sci U S A (2008) 1.44
Beta interferon controls West Nile virus infection and pathogenesis in mice. J Virol (2011) 1.23
IκB kinase epsilon (IKK(epsilon)) regulates the balance between type I and type II interferon responses. Proc Natl Acad Sci U S A (2011) 1.23
Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein. J Gen Virol (2009) 1.16
Evolution of the interferon alpha gene family in eutherian mammals. Gene (2007) 1.12
A fluorescence reporter model defines "Tip-DCs" as the cellular source of interferon β in murine listeriosis. PLoS One (2010) 1.02
IFN-α subtypes: distinct biological activities in anti-viral therapy. Br J Pharmacol (2013) 1.02
Macrophages and cytokines in the early defence against herpes simplex virus. Virol J (2005) 1.00
Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. PLoS Pathog (2012) 0.97
Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells. J Interferon Cytokine Res (2008) 0.95
Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection. PLoS One (2015) 0.95
Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo. J Virol (2011) 0.93
An essential role for IFN-β in the induction of IFN-stimulated gene expression by LPS in macrophages. J Leukoc Biol (2014) 0.92
Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus. J Innate Immun (2009) 0.92
IFN-ε is constitutively expressed by cells of the reproductive tract and is inefficiently secreted by fibroblasts and cell lines. PLoS One (2013) 0.91
IFN-alpha expression and antiviral effects are subtype and cell type specific in the cardiac response to viral infection. Virology (2009) 0.90
Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes. Retrovirology (2011) 0.90
Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease. J Virol (2008) 0.89
Deficiency of the myeloid differentiation primary response molecule MyD88 leads to an early and rapid development of Helicobacter-induced gastric malignancy. Infect Immun (2013) 0.89
Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons. DNA Cell Biol (2011) 0.89
Human but not mouse hepatocytes respond to interferon-lambda in vivo. PLoS One (2014) 0.88
Interaction of hepatitis C virus with the type I interferon system. World J Gastroenterol (2007) 0.88
Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas. J Immunother (2013) 0.87
Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-alpha/beta. Am J Pathol (2008) 0.87
Inefficient type I interferon-mediated antiviral protection of primary mouse neurons is associated with the lack of apolipoprotein l9 expression. J Virol (2014) 0.83
Management of chronic hepatitis C treatment failures: role of consensus interferon. Biologics (2009) 0.83
Reactive oxygen species and IRF1 stimulate IFNα production by proximal tubules during ischemic AKI. Am J Physiol Renal Physiol (2013) 0.82
The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons. Front Cell Infect Microbiol (2014) 0.80
Thogoto virus infection induces sustained type I interferon responses that depend on RIG-I-like helicase signaling of conventional dendritic cells. J Virol (2010) 0.79
Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication. J Virol (2014) 0.78
Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells. Exp Diabetes Res (2009) 0.78
Interferon Alpha Characterization and Its Comparative Expression in PBM Cells of Capra hircus and Antelope cervicapra Cultured in the Presence of TLR9 Agonist. Mol Biol Int (2010) 0.77
A functional polymorphism in IFNAR1 gene is associated with susceptibility and severity of HFMD with EV71 infection. Sci Rep (2015) 0.76
The Interferon-Inducible Mouse Apolipoprotein L9 and Prohibitins Cooperate to Restrict Theiler's Virus Replication. PLoS One (2015) 0.75
Differential Biological Activities of Swine Interferon-α Subtypes. J Interferon Cytokine Res (2015) 0.75
In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection. J Virol (2016) 0.75
Lung epithelial cells have virus-specific and shared gene expression responses to infection by diverse respiratory viruses. PLoS One (2017) 0.75
Type I interferon is required for T helper (Th) 2 induction by dendritic cells. EMBO J (2017) 0.75
Investigation of chimeric reads using the MinION. F1000Res (2017) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res (1988) 32.89
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol (2003) 15.67
IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol (2002) 11.87
Triggering the interferon antiviral response through an IKK-related pathway. Science (2003) 11.62
IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol (2002) 11.22
Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity (2000) 10.34
Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J (1998) 7.20
Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem (2001) 3.26
Cloning and synthesis of infectious cardiovirus RNAs containing short, discrete poly(C) tracts. J Virol (1989) 2.56
Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem (2004) 2.55
Structure and expression of cloned murine IFN-alpha genes. Nucleic Acids Res (1983) 2.35
Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. Curr Opin Immunol (2003) 1.78
The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J Virol (2001) 1.75
Interferon-kappa, a novel type I interferon expressed in human keratinocytes. J Biol Chem (2001) 1.45
Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. J Biol Chem (2003) 1.39
Characterization of a mouse interferon gene locus I. Isolation of a cluster of four alpha interferon genes. Nucleic Acids Res (1985) 1.27
Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2. J Mol Biol (1999) 1.26
Organization, structure and expression of murine interferon alpha genes. Nucleic Acids Res (1985) 1.24
A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci U S A (1984) 1.23
Structure of the human type-I interferon gene cluster determined from a YAC clone contig. Genomics (1994) 1.20
Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. Biochem J (2003) 1.20
Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors. Nat Med (2000) 1.14
Biological activities and receptor binding of two human recombinant interferons and their hybrids. J Gen Virol (1986) 1.14
Various human interferon alpha subclasses cross-react with common receptors: their binding affinities correlate with their specific biological activities. Virology (1984) 1.14
Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J Biol Chem (2003) 1.12
Cell type specific expression and regulation of murine interferon alpha and beta genes. Virology (1989) 1.08
Type I interferon differential therapy for erythroleukemia: specificity of STAT activation. Blood (2002) 0.98
Biologic and binding activities of IFN-alpha subtypes in ACHN human renal cell carcinoma cells and Daudi Burkitt's lymphoma cells. J Interferon Cytokine Res (1999) 0.94
Natural human interferon-alpha 2 is O-glycosylated. Biochem J (1991) 0.93
The evolution of the type I interferon gene family in mammals. J Mol Evol (1995) 0.93
Expression of a novel murine type I IFN in the pancreatic islets induces diabetes in mice. J Immunol (2003) 0.92
Isolation and bacterial expression of a murine alpha leukocyte interferon gene. J Interferon Res (1984) 0.89
Isolation and characterization of a novel interferon-alpha-encoding gene, IFN-alpha 11, within a murine IFN cluster. Gene (1991) 0.86
Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antiviral Res (2002) 0.86
Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. Gene (1986) 0.85
Structure-function analysis of murine interferon-alpha: antiviral properties of novel hybrid interferons. J Interferon Res (1988) 0.85
Properties of natural and hybrid murine alpha interferons. J Gen Virol (1986) 0.85
Isolation and characterization of a functional murine interferon alpha gene which is not expressed in fibroblasts upon virus induction. J Gen Virol (1989) 0.84
Structure and characterization of a murine chromosomal fragment containing the interferon beta gene. J Mol Biol (1988) 0.84
Purification and characterization of natural human interferon omega 1. Two alternative cleavage sites for the signal peptidase. J Biol Chem (1990) 0.83
Sequence and expression of a novel murine interferon alpha gene--homology with enhancer elements in the regulatory region of the gene. Biochem Biophys Res Commun (1986) 0.83
Structure of a murine alpha interferon pseudogene with a repetitive R-type sequence in the 3' flanking region. Mol Cell Biol (1985) 0.82
The virus-induced factor VIF differentially recognizes the virus-responsive modules of the mouse IFNA4 gene promoter. J Interferon Cytokine Res (2002) 0.81
Structural characterisation of N-linked and O-linked oligosaccharides derived from interferon-alpha2b and interferon-alpha14c produced by Sendai-virus-induced human peripheral blood leukocytes. Eur J Biochem (1998) 0.81
Differential constitutive expression of interferon genes in early mouse embryos. Mol Reprod Dev (1995) 0.79
Structure-function analysis of mouse interferon alpha species: MuIFN-alpha 10, a subspecies with low antiviral activity. J Gen Virol (1988) 0.78
Two domains in alpha interferons influence the efficacy of the antiviral response. Biochem Biophys Res Commun (1987) 0.78
Purification and carbohydrate structure of natural murine interferon-beta. Eur J Biochem (1988) 0.78
Antiviral and antiproliferative activities of interferon-alpha 1: the role of cysteine residues. J Interferon Res (1986) 0.77
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature (2008) 10.15
IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog (2008) 4.70
IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A (2009) 3.31
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med (2008) 3.24
Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem (2002) 2.73
NetPath: a public resource of curated signal transduction pathways. Genome Biol (2010) 2.62
IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J Immunol (2007) 2.60
Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem (2004) 2.55
IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A (2011) 2.47
Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog (2008) 2.38
IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J Immunol (2002) 2.32
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Annu Rev Microbiol (2005) 2.26
Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A (2006) 2.02
IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J Immunol (2011) 1.92
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol (2007) 1.90
Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis. Am J Respir Crit Care Med (2011) 1.78
IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med (2013) 1.75
Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum (2009) 1.70
The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J Virol (2004) 1.58
Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res (2003) 1.53
IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. J Immunol (2009) 1.48
The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3. Cell Microbiol (2007) 1.47
IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells. J Immunol (2007) 1.44
The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J Immunol (2009) 1.44
IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors (2004) 1.43
TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa. J Immunol (2010) 1.43
Non-AUG-initiated internal translation of the L* protein of Theiler's virus and importance of this protein for viral persistence. J Virol (2002) 1.41
The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains. J Biol Chem (2004) 1.38
Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. Am J Respir Crit Care Med (2011) 1.38
Type I interferon response in the central nervous system. Biochimie (2007) 1.29
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol (2006) 1.28
Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol (2004) 1.28
Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness. J Gen Virol (2006) 1.27
IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J Immunol (2010) 1.25
Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism. FEBS Lett (2008) 1.22
Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. Biochem J (2003) 1.20
Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity. J Virol (2002) 1.16
Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein. J Gen Virol (2009) 1.16
The leader protein of cardioviruses inhibits stress granule assembly. J Virol (2011) 1.14
IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS One (2011) 1.13
Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis. J Allergy Clin Immunol (2010) 1.13
Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors. Haematologica (2011) 1.12
Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J Biol Chem (2003) 1.12
A profibrotic function of IL-12p40 in experimental pulmonary fibrosis. J Immunol (2002) 1.11
Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis. Ann N Y Acad Sci (2007) 1.11
Crystal structure of recombinant human interleukin-22. Structure (2002) 1.08
Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers. J Biol Chem (2009) 1.07
Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice. Oncogene (2003) 1.07
IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J Allergy Clin Immunol (2011) 1.06
CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I. Eur J Immunol (2003) 1.06
Profibrotic effect of IL-9 overexpression in a model of airway remodeling. Am J Respir Cell Mol Biol (2007) 1.05
Random mutagenesis defines a domain of Theiler's virus leader protein that is essential for antagonism of nucleocytoplasmic trafficking and cytokine gene expression. J Virol (2009) 1.03
Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice. Immunity (2013) 1.03
Evasion of antiviral innate immunity by Theiler's virus L* protein through direct inhibition of RNase L. PLoS Pathog (2013) 1.02
Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions. Eur Cytokine Netw (2002) 1.00
IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection. PLoS One (2013) 0.97
The paralogous salivary anti-complement proteins IRAC I and IRAC II encoded by Ixodes ricinus ticks have broad and complementary inhibitory activities against the complement of different host species. Microbes Infect (2006) 0.97
Structure and function of interleukin-22 and other members of the interleukin-10 family. Cell Mol Life Sci (2010) 0.97
IL-9 promotes but is not necessary for systemic anaphylaxis. J Immunol (2005) 0.96
The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response. Immunology (2007) 0.96
Interferon-λ in the context of viral infections: production, response and therapeutic implications. J Innate Immun (2014) 0.96
Cancer risk in immune-mediated inflammatory diseases (IMID). Mol Cancer (2013) 0.95
New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain. J Biol Chem (2009) 0.94
IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection. Eur J Immunol (2013) 0.93
IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven immunopathology. J Immunol (2012) 0.93
IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysaccharide-stimulated human monocytes through TGF-beta. J Immunol (2002) 0.92
N-glycosylation of murine IFN-beta in a putative receptor-binding region. J Interferon Cytokine Res (2006) 0.92
What have we learned from the IL28 receptor knockout mouse? J Interferon Cytokine Res (2010) 0.91
Proapoptotic activity of ITM2B(s), a BH3-only protein induced upon IL-2-deprivation which interacts with Bcl-2. Oncogene (2002) 0.91
IFN-ε is constitutively expressed by cells of the reproductive tract and is inefficiently secreted by fibroblasts and cell lines. PLoS One (2013) 0.91
Differential IFN-alpha/beta production suppressing capacities of the leader proteins of mengovirus and foot-and-mouth disease virus. Cell Microbiol (2009) 0.90
Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain. J Biol Chem (2008) 0.90
ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon. Blood (2010) 0.90
IL-9-induced expansion of B-1b cells restores numbers but not function of B-1 lymphocytes in xid mice. J Immunol (2004) 0.89
Idiopathic basal ganglia calcification-associated PDGFRB mutations impair the receptor signalling. J Cell Mol Med (2014) 0.89
Interleukin-9 promotes eosinophilic rejection of mouse heart allografts. Transplantation (2003) 0.89
Antiviral type I and type III interferon responses in the central nervous system. Viruses (2013) 0.88
Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells. PLoS One (2007) 0.87
Type I interferon signaling contributes to chronic inflammation in a murine model of silicosis. Toxicol Sci (2010) 0.87
Structural features of the KPI domain control APP dimerization, trafficking, and processing. FASEB J (2011) 0.87
A new member of the interleukin 10-related cytokine family encoded by a poxvirus. J Gen Virol (2004) 0.86
Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22. FEBS Lett (2009) 0.86
Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains. Biophys J (2007) 0.85
IL-22 is produced by γC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality. Eur J Immunol (2011) 0.84
B lymphocytes are critical for lung fibrosis control and prostaglandin E2 regulation in IL-9 transgenic mice. Am J Respir Cell Mol Biol (2006) 0.84
IL-1α induces CD11b(low) alveolar macrophage proliferation and maturation during granuloma formation. J Pathol (2015) 0.84
Inefficient type I interferon-mediated antiviral protection of primary mouse neurons is associated with the lack of apolipoprotein l9 expression. J Virol (2014) 0.83
TLR Ligand-Induced Type I IFNs Affect Thymopoiesis. J Immunol (2008) 0.83
Interleukin-9 stimulates the production of interleukin-5 in CD4+ T cells. Eur Cytokine Netw (2005) 0.83
MAP kinase activation by interleukin-9 in lymphoid and mast cell lines. Oncogene (2003) 0.83
Dual TCR expression biases lung inflammation in DO11.10 transgenic mice and promotes neutrophilia via microbiota-induced Th17 differentiation. J Immunol (2011) 0.83
Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice. Clin Vaccine Immunol (2010) 0.83
Theiler's virus L protein is targeted to the mitochondrial outer membrane. J Virol (2011) 0.82
Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway. Neurol Res (2007) 0.81
Divergent roles of IFNs in the sensitization to endotoxin shock by lactate dehydrogenase-elevating virus. Int Immunol (2007) 0.81
Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice. PLoS One (2013) 0.81
C-terminal clipping of chemokine CCL1/I-309 enhances CCR8-mediated intracellular calcium release and anti-apoptotic activity. PLoS One (2012) 0.80